Literature DB >> 10777182

Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection.

T I Huo1, J C Wu, P C Lee, S H Tsay, F Y Chang, S D Lee.   

Abstract

Liver cirrhosis may occur in chronic hepatitis B surface antigen (HBsAg) carriers. Diabetes mellitus (DM)-associated chronic hepatitis may also occasionally lead to cirrhosis; however, its role in the course of chronic HBsAg carriers has not been studied. A cohort of 500 HBsAg carriers (398 men; mean age at entry, 42 +/- 15 years) were followed up longitudinally. After a mean follow-up of 5.8 +/- 3.3 years, 71 (14.2%: 70 men) patients developed cirrhosis. Increased risks of cirrhosis were found among men and the elderly (p < 0.001). Fifteen (21.1%) cirrhotic patients were noted to have had DM for 2-15 years before the development of cirrhosis. By contrast, only eight (1.9%; p < 0.001 ) of the patients without cirrhosis developed DM. When cirrhotic patients were compared to 102 age- and sex-matched non-cirrhotic controls, DM and elevation of serum alanine transaminase levels were found to be independent factors associated with the advent of cirrhosis in multivariate analysis. Other factors, including acute exacerbation, bridging hepatic necrosis, and superinfection by hepatitis C or D viruses, were insignificant. Our results suggest that DM may play a role in the progression to liver cirrhosis in chronic HBsAg carriers. High-risk subjects should be closely monitored for late complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777182     DOI: 10.1097/00004836-200004000-00009

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

1.  Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes.

Authors:  Jeff Y Yang; Andrew M Moon; Hannah Kim; Virginia Pate; A Sidney Barritt; Matthew J Crowley; John B Buse; Til Stürmer; Anastasia-Stefania Alexopoulos
Journal:  J Diabetes Complications       Date:  2020-08-05       Impact factor: 2.852

2.  Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis.

Authors:  Olivier Van Der Meeren; Priya Crasta; Brigitte Cheuvart; Marc De Ridder
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Prevalence of and factors influencing impaired glucose tolerance among hepatitis B carriers: a nationwide cross-sectional study in the Republic of Korea.

Authors:  Boyoung Park; Kyu-Won Jung; Chang-Mo Oh; Kui Son Choi; Mina Suh; Jae Kwan Jun
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

4.  The double burden of diabetes and global infection in low and middle-income countries.

Authors:  Susanna Dunachie; Parinya Chamnan
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-02-01       Impact factor: 2.184

5.  Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China.

Authors:  Yanbing Zhou; Yan Cui; Haiju Deng; Jinming Yu
Journal:  BMC Public Health       Date:  2014-05-28       Impact factor: 3.295

6.  Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents.

Authors:  Jung-Ho Shin; Hee Jin Kwon; Hye Ryoun Jang; Jung Eun Lee; Geum-Youn Gwak; Wooseong Huh; Sin-Ho Jung; Joon Hyeok Lee; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.